B24
Conditions
Interventions
Group 1: In the clinical setting, several new HIV diagnoses among PWID were identified at the study center over a five-year period (2021–2025). This raises the question of whether an epidemiological l
Sponsors
Medizinische Klinik I, Universitätsklinikum Bonn
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: HIV, drug use
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In the clinical setting, several new HIV diagnoses among PWID were identified at the study center over a five-year period (2021–2025). The aim of the study is to identify all new HIV diagnoses among PWID at the study center. Subsequently, molecular phylogenetic analyses of HIV sequences will be performed to investigate potential transmission links. The present study therefore seeks to analyze the clinical, epidemiological, and molecular characteristics of these cases. | — |
Countries
Germany
Contacts
Public ContactJürgen Rockstroh
Medizinische Klinik 1, Universitätsklinikum Bonn
Outcome results
None listed